4.6 Article

Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men

Journal

ATHEROSCLEROSIS
Volume 225, Issue 2, Pages 475-480

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2012.09.015

Keywords

Arteriosclerosis; Hypertension; Risk factors; Pulse wave velocity; Stiffness

Funding

  1. NIH [R01 HL68200, HL071561]
  2. Japanese Ministry of Education, Culture, Sports, Science and Technology [B 16790335, A 13307016, 17209023, 21249043]
  3. Grants-in-Aid for Scientific Research [21249043, 17209023] Funding Source: KAKEN

Ask authors/readers for more resources

Objective: Limited data are available about risk factors for the progression of aortic stiffness in healthy population. We examined several risk factors as possible independent predictors of aortic stiffness progression among a population-based sample of US men. Methods: A total of 240 men (40-49 years) free of CVD at baseline from the Pittsburgh site of the ERA JUMP study were evaluated. Aortic stiffness was measured as carotid-femoral pulse wave velocity at baseline and after 4.6 +/- 0.2 (mean +/- SD) years of follow-up. Progression of aortic stiffness was evaluated as relative annual change in carotid-femoral pulse wave velocity (% change/year). Using linear regression, both baseline potential risk factors and their annual changes were evaluated as possible risk factors for aortic stiffness progression. Baseline age, follow-up time, race, heart rate, and medications use were forced in all models. Results: During follow-up, relative to baseline level, aortic stiffness increased 0.3% +/- 5.3% per year. In final models, the independent predictors of degree of aortic stiffness progression were lower levels of adiponectin (P = 0.03), higher levels of systolic blood pressure (P = 0.03), greater annual change in systolic blood pressure (P = 0.04), and alcohol consumption >= 2 times/week (P = 0.02). Adiponectin levels within the third (9.8 mu g/Ml <= adiponectin < 13.0 mu g/mL) and the fourth (adiponectin >= 13.0 mu g/mL) quartiles were associated with an improvement in relative annual aortic stiffness progression (P = 0.02, P = 0.01, respectively) compared to levels within the first quartile (adiponectin <= 7.0 mu g/mL). Conclusion: Among apparently healthy men, lower levels of baseline adiponectin could be a novel marker for greater risk of aortic stiffness progression. Longitudinal research is required to evaluate whether adiponectin change over time would have similar association with aortic stiffness progression. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available